Your browser doesn't support javascript.
loading
Repression of sphingosine kinase (SK)-interacting protein (SKIP) in acute myeloid leukemia diminishes SK activity and its re-expression restores SK function.
Ghazaly, Essam A; Miraki-Moud, Farideh; Smith, Paul; Gnanaranjan, Chathunissa; Koniali, Lola; Oke, Adedayo; Saied, Marwa H; Petty, Robert; Matthews, Janet; Stronge, Randal; Joel, Simon P; Young, Bryan D; Gribben, John; Taussig, David C.
Afiliação
  • Ghazaly EA; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Miraki-Moud F; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom; Institute of Cancer Research, Sutton, London, United Kingdom.
  • Smith P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Gnanaranjan C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Koniali L; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Oke A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Saied MH; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Petty R; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Matthews J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Stronge R; Institute of Cancer Research, Sutton, London, United Kingdom; Department of Haematology, Royal Marsden Hospital, Sutton, United Kingdom.
  • Joel SP; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Young BD; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
  • Taussig DC; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom; Institute of Cancer Research, Sutton, London, United Kingdom; Department of Haematology, Royal Marsden Hospital, Sutton, United Kingdom. Electronic address: e.a.ghazaly@qmul.ac.uk.
J Biol Chem ; 295(16): 5496-5508, 2020 04 17.
Article em En | MEDLINE | ID: mdl-32161116
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Fosfotransferases (Aceptor do Grupo Álcool) / Proteínas Adaptadoras de Transdução de Sinal Limite: Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Fosfotransferases (Aceptor do Grupo Álcool) / Proteínas Adaptadoras de Transdução de Sinal Limite: Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2020 Tipo de documento: Article